Exploiting oxidative stress and signaling in chemotherapy of resistant neoplasms

Biochemistry (Moscow)

Volumn 69, Issue 1, 2004, Pages 38-44

  Schor, N F ^a,c   Kagan, V E ^a,b   Liang, Ye ^a,c   Yan, Ch ^c   Tyurina, Yu ^b   Tyurin, V ^b   Nylander, K D ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Apoptosis; Chemotherapeutic agents; Neural crest tumor cells; Oxidative stress

Indexed keywords

CELLS; CHEMOTHERAPY; NITROGEN; REDUCTION; STRESS ANALYSIS; TOXICITY; TUMORS;

APOPTOSIS; CHEMOTHERAPEUTIC AGENTS; NEURAL CREST TUMOR CELLS; OXIDATIVE STRESS;

DISEASE CONTROL;

CATECHOLAMINE; GLUTATHIONE; PROTEIN BCL 2;

ANIMAL; DRUG RESISTANCE; GENETICS; METABOLISM; NEOPLASM; OXIDATIVE STRESS; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CATECHOLAMINES; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; NEOPLASMS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 3543136716     PISSN: 00062979     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BIRY.0000016349.75384.e6     Document Type: Conference Paper

References (37)

1. Schor, N. F. (1999) J. Neuro-Oncol., 41, 159-166.
2. Chelmicka-Szorc, E., and Arnason, B. G. W. (1976) Cancer Res., 36, 2382-2384.
3. Reynolds, C. P., and Perez-Polo, J. R. (1981) Neurosci. Lett., 26, 151-155.
4. Schor, N. F. T. (1987) Cancer Res., 47, 5411-5414.
5. Thoenen, H., and Tranzer, J. P. (1968) Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmacol., 261, 271-288.
6. Purpura, P., Westman, L., Will, P., Eidelman, A., Kagan, V. E., Osipov, A. N., and Schor, N. F. (1996) Cancer Res., 56, 2336-2342.
7. Chateauneuf, J., Lusztyk, J., and Ingold, K. U. (1988) J. Org. Chem., 53, 1629-1632.
8. Samuni, A., Mitchell, J. B., Krishna, C. M., Samuni, U., and Russo, A. (1991) Free Rad. Res. Commun., 12/13, 197-194.
9. Samuni, A., Winkelsberg, D., Pinson, A., Hahn, S. M., Mitchell, J. B., and Russo, A. (1991) J. Clin. Invest., 87, 1526-1530.
10. Hahn, S. M., Tochner, Z., Murali Krishna, C., Glass, J., Wilson, L., Samuni, A., Sprague, M., Venzon, D., Glatstein, E., Mitchell, J. B., and Russo, A. (1992) Cancer Res., 52, 1750-1753.
11. Dole, M., Nunez, G., Merchant, A. K., Maybaum, J., Rode, C. K., Bloch, C. A., and Castle, V. P. (1994) Cancer Res., 54, 3253-3259.
12. Dole, M., Jasty, R., Cooper, M. J., Thompson, C. B., and Nunez, G. (1995) Cancer Res., 55, 2576-2582.
13. Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Ord, T., and Bredesen, D. E. (1993) Science, 262, 1274-1277.
14. Albrecht, H., Tschopp, J., and Jongeneel, C. V. (1994) FEBS Lett., 351, 45-48.
15. Tyurina, Y. Y., Tyurin, V. A., Carta, G., Quinn, P. H., Schor, N. F., and Kagan, V. E. (1997) Arch. Biochem. Biophys., 344, 412-413.
16. Schor, N. F., Rudin, C. M., Hartmann, A.-R., Thompson, C. B., Tyurina, Y. Y., and Kagan, V. E. (2000) Oncogene, 19, 472-476.
17. Ratan, R. R., Murphy, T. H., and Baraban, J. M. (1994) J. Neurosci., 14, 4385-4392.
18. Sandstrom, P. A., Mannie, M. D., and Buttke, T. M. (1994) J. Leukoc. Biol., 55, 221-226.
19. Forrest, V. J., Kang, Y. H., McClain, D. E., Robinson, D. H., and Ramakrishnan, N. (1994) Free Rad. Biol. Med., 16, 675-684.
20. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-L, Jones, D. P., and Wang, X. (1997) Science, 275, 1129-1132.
21. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. (1997) Science, 275, 1132-1136.
22. Cortazzo, M. H., and Schor, N. F. (1996) Cancer Res., 56, 1199-1203.
23. Hartsell, T. L., Yalowich, J. C., Ritke, M., Martinez, A. J., and Schor, N. F. (1995) J. Pharm. Exp. Ther., 275, 479-485.
24. Hartsell, T. L., Hinman, L. M., Hamann, P. R., and Schor, N. F. (1996) J. Pharm. Exp. Ther., 277, 1158-1166.
25. Beerman, T. A., Poon, R., and Goldberg, I. H. (1977) Biochim. Biophys. Acta, 475, 294-306.
26. DeGraff, W. G., and Mitchell, J. B. (1985) Cancer Res., 45, 4760-4762.
27. Schor, N. F. (1992) J. Clin. Invest., 89, 774-781.
28. Schor, N. F., Tyurina, Y. Y., Fabisiak, J. P., Tyurin, V. A., Lazo, J. S., and Kagan, V. E. (1999) Brain Res., 831, 125-130.
29. Liang, Y., Nylander, K. D., and Schor, N. F. (2002) Mol. Pharmacol., 61, 142-149.
30. Steinman, H. M. (1995) J. Biol. Chem., 270, 3487-3490.
31. Hubel, C. A., Kagan, V. E., Kisin, E. R., McLaughlin, M. K., and Roberts, J. M. (1997) Free Rad. Biol. Med., 23, 596-609.
32. Stoyanovsky, D. A., Goldman, R., Jonnalagadda, S. S., Day, B. W., Claycamp, H. G., and Kagan, V. E. (1996) Arch. Biochem. Biophys., 330, 3-11.
33. Langmuir, M. E., Yang, J.-R., LeCompte, K. A., and Durand, R. E. (1996) Fluorescence Microscopy and Fluorescent Probes, Plenum Press, N. Y., pp. 229-234.
34. Liang, Y., Yan, C., and Schor, N. F. (2001) Oncogens, 20, 6570-6578.
35. DeGraff, W. G., Russo, A., and Mitchell, J. B. (1985) J. Biol. Chem., 260, 8312-8315.
36. Bonilla, M. A., and Cheung, N.-K. V. (1994) Cancer Invest., 12, 644-653.
37. Johnson, F. L., and Goldman, S. (1993) Hematol. Oncol. Clin. N. Amer., 7, 647-662.